Global blockchain supervision and query platform

English
Download

Can Amgen keep the beat streak alive this earnings season?

Can Amgen keep the beat streak alive this earnings season? WikiBit 2025-04-30 02:26

Amgen (AMGN - Free Report) will report first-quarter 2025 results on May 1, after market close. In the last reported quarter, the company beat earnings

Our proven model does not conclusively predict an earnings beat for Amgen this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here.

Earnings ESP: Amgen‘s Earnings ESP is -0.05%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: Amgen has a Zacks Rank #3.

Stocks to consider

Here are some drug/biotech stocks that have the right combination of elements to beat on earnings this time around:

Exelixis (EXEL – Free Report) has an Earnings ESP of +7.14% and a Zacks Rank #3. You can see the complete list of todays Zacks #1 Rank stocks here.

Exelixis stock has risen 15.5% so far this year. Exelixis beat earnings estimates in three of the last four quarters while missing in one. EXEL has a four-quarter earnings surprise of 26.87%, on average.

Blueprint Medicines (BPMC – Free Report) has an Earnings ESP of +84.44% and a Zacks Rank #3.

Blueprint Medicines stock has risen 1.5% so far this year. BPMC beat earnings estimates in three of the last four quarters while missing in the remaining quarter. On average, BPMC delivered an earnings surprise of 13.10% in the last four quarters.

Denali Therapeutics (DNLI – Free Report) has an Earnings ESP of +4.87% and a Zacks Rank #3.

Denalis stock has risen 20.2% year to date. DNLI missed earnings estimates in two of the last four quarters while beating on the remaining two occasions. On average, Denali witnessed an earnings surprise of 6.51% in the last four quarters.

Zacks names #1 semiconductor stock

Its only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.

With strong earnings growth and an expanding customer base, its positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.

Disclaimer:

The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

  • Crypto token price conversion
  • Exchange rate conversion
  • Calculation for foreign exchange purchasing
/
PC(S)
Current Rate
Available

0.00